Invenomic Capital Management’s Gold Standard Ventures Corp. GSV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,480,795
Closed -$464K 205
2022
Q2
$464K Sell
1,480,795
-704,221
-32% -$280K 0.03% 142
2022
Q1
$773K Buy
2,185,016
+107,571
+5% +$46.6K 0.08% 138
2021
Q4
$921K Buy
2,077,445
+1,826,770
+729% +$843K 0.2% 112
2021
Q3
$114K Sell
250,675
-184,032
-42% -$93.3K 0.04% 116
2021
Q2
$243K Sell
434,707
-77,367
-15% -$45.5K 0.06% 110
2021
Q1
$297K Sell
512,074
-55,384
-10% -$37.5K 0.07% 110
2020
Q4
$411K Buy
567,458
+272,308
+92% +$197K 0.1% 104
2020
Q3
$230K Buy
295,150
+111,143
+60% +$94.5K 0.13% 125
2020
Q2
$150K Buy
+184,007
New +$121K 0.11% 142

Invenomic Capital Management's GSV Position: Q3 2022 in Review

Invenomic Capital Management sold out of Gold Standard Ventures Corp. (GSV) in Q3 2022, closing a stake of 1,480,795 shares — an estimated $464K sold.

Invenomic Capital Management first reported a position in GSV in Q2 2020 and held it in 9 quarters. The position peaked at $921K in Q4 2021. 0 funds tracked by Wall St. Rank hold GSV as of Q3 2022.

  • Invenomic Capital Management reported no remaining Gold Standard Ventures Corp. position as of Q3 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 1,480,795 Gold Standard Ventures Corp. shares in Q3 2022, an estimated $464K.
  • Invenomic Capital Management first reported a position in Gold Standard Ventures Corp. in Q2 2020 and held it in 9 quarters.
  • Invenomic Capital Management's Gold Standard Ventures Corp. position peaked at $921K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Gold Standard Ventures Corp. as of Q3 2022.

Based on Invenomic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.